Top Asian Stocks Priced Below Their True Value by 42.1%

As international markets face trade instabilities and shifts in policy direction, Asian equities are garnering interest due to varied performance among principal indexes. The possibility of economic stimulus in China and prudent monetary strategies in Japan could present investors with chances to invest in undervalued stocks available at marked-down prices. In this kind of environment, valuable stocks are typically distinguished by robust fundamentals and the ability to withstand external pressures, thereby presenting potential value amidst market volatility.

Click here to see the full list of 271 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let’s delve deeper into a few selected stocks from the listed companies.

Overview: Shanghai OPM Biosciences Co., Ltd. specializes in cell culture media and CDMO services, catering to both domestic and international markets with a market capitalization of CN¥4.85 billion.

Operations: Shanghai OPM Biosciences generates its revenue from the provision of cell culture media and CDMO services locally and abroad.

Estimated Discount To Fair Value: 42.1%

The stock is currently trading at CN¥43.19, which is significantly lower than its estimated fair value of CN¥74.58, suggesting possible undervaluation based on cash flow analysis. Despite a drop in net income to CNY 21.13 million from CNY 54.04 million year-over-year, projected earnings are set to grow at 47.4% annually over the next three years, substantially outpacing the average growth rate of 23.6% in the Chinese market. However, there’s been a decline in profit margins from 22.2% to 7.1%.

Overview: Hangzhou Zhongtai Cryogenic Technology Corporation focuses on developing, designing, manufacturing, and selling cryogenic equipment within China, with a market capitalization of CN¥5.25 billion.

Operations: Their revenue primarily comes from the development, design, manufacturing, and distribution of cryogenic equipment in the domestic market.

Estimated Discount To Fair Value: 11.3%

Currently, Hangzhou Zhongtai trades at CN¥13.81, slightly below its estimated fair value of CN¥15.58, indicating a mild undervaluation based on cash flows. Although there was a decrease in annual revenue to CN¥2.71 billion compared to last year, net income for Q1 2025 increased to CN¥100.23 million from CN¥70.17 million a year earlier, hinting at improved profitability ahead with significant expected earnings growth over the next three years.

Overview: KATITAS CO., Ltd. operates in Japan, focusing on the surveying, purchasing, refurbishing, remodeling, and selling of used homes to individuals and families, representing a market capitalization of ¥165.86 billion.

Operations: The company earns most of its revenue through its House for Resale Reproduction Business, which reported ¥129.69 billion in revenue.

Estimated Discount To Fair Value: 39.4%

KATITAS is currently trading at ¥2,121, which is considerably lower than its estimated fair value of ¥3,498.09, suggesting an undervaluation based on cash flows. The firm anticipates an annual earnings growth of 9.23%, exceeding the average market growth in Japan of 7.7%. Revenue is also projected to rise by 8.1% per annum, surpassing the market average of 4.3%. Nevertheless, KATITAS displays an inconsistent dividend history despite optimism regarding future profitability and a strong anticipated return on equity over the next three years.

This article by Simply Wall St is for informational purposes only. Our insights are grounded in historical data and analyst predictions derived from an impartial methodology and are not intended as financial advice. This does not constitute a recommendation for buying or selling any stock and does not consider your personal objectives or financial circumstances. We focus on long-term analytical insights driven by fundamental data. Be aware that our assessments may not incorporate recent price-sensitive company announcements or qualitative changes. Simply Wall St holds no positions in any stocks mentioned.

Companies discussed in this article include SHSE:688293, SZSE:300435, and TSE:8919.

If you have any feedback on this article or concerns about the content, please contact us directly. Alternatively, email editorial-team@simplywallst.com